Intas Pharmaceuticals Walk In Drive at Matoda

 

opportunities with Intas Pharmaceuticals Walk In Drive at Matoda




 About Company

Intas is a leading, vertically integrated global pharmaceutical formulation development, manufacturing, and marketing company. Intas is committed to challenging the unmet medical and societal needs through a comprehensive pharmaceutical value chain spanning across the world.

Intas has set up a network of subsidiaries, under the umbrella name of Accord Healthcare to operate in global markets. Over the years, Intas has grown both organically and via acquisition, expanding its product portfolio and operations year on year. It is currently present in more than 85 countries worldwide with robust sales, marketing and distribution infrastructure in markets like North America, Europe, Central & Latin America, Asia-Pacific as well as CIS and MENA countries. Intas’ remarkable success in North America and European operations have helped us emerge as a global brand in the world’s largest pharmaceutical markets.

Venue: Intas Pharmaceuticals Ltd, Matoda Plot No. 457, 458 Sarkhej Bavla Highway, Matoda Village, Sanand, Taluka, Ahmedabad, Gujarat 382210.

 

Date: 6th January 2024, Saturday

Time: 09:30 AM to 03:00 PM

Position: Officer / Sr. Officer / Executive / Sr. Executive

Department: Quality Assurance - Validation & Qualification (Injectable / OSD) & Analytical Review (Micro & QC)

Qualification: B.Pharm / M.Pharm / M.Sc with relevant functional experience

Experience: 02 to 08 years

 

Position: Officer / Sr. Officer / Executive / Sr. Executive Department: Quality Control Quality Control & Microbiology - Supervisor / Analyst

Qualification: B.Sc / M.Sc (Organic Chemistry / Analytical Chemistry / Microbiology), B.Pharm / M.Pharm

Experience: 02 to 08 years

Comments

Popular posts from this blog

Emcure Pharmaceuticals Ltd is Hiring!!!

Cipla Limited – Walk-In Interviews on 19th Sep’ 2024 for Multiple Positions

Emcure walk in interview for QA, QC, Engineering, Production & Packing on 4th February 2024